Alcohol · Using · Question 13 of 35

Can I drink alcohol?

The labels do not ban alcohol, and they do not list an interaction. That is not the same as saying it does not matter. Here is what is known, including why so many users say they have lost interest in drinking.

By Dr. Chiranjeevi Peetla · Updated November 2026 · 4 min read · 4 sources, each linked

What the labels say

The drug-interaction sections of the Wegovy and Zepbound labels cover slower absorption of oral medicines, low blood sugar with insulin or sulfonylureas, and (for Zepbound) oral contraceptives. Neither lists alcohol.[1][2]

Where alcohol matters

  • Nausea. The NHS advises that alcohol can make semaglutide's nausea worse.[3]
  • Low blood sugar. For people with diabetes on insulin or a sulfonylurea, the labels already warn about hypoglycemia, and alcohol lowers blood sugar too.[1][2]
  • Pancreas. Pancreatitis is a listed warning for these drugs, and heavy drinking is a well-known cause of pancreatitis on its own; the labels do not quantify any combined risk.[1][2]
  • Dehydration. Alcohol adds to fluid loss in a body that may already be drinking less.[1][2]

Losing interest in drinking

This is one of the most common forum observations, and there is now trial evidence behind it. In a 9-week randomized trial in 48 adults with alcohol use disorder, low-dose semaglutide (up to 1 mg) reduced how much people drank in a lab session, drinks per drinking day and weekly craving, but did not reduce the number of drinking days.[4] It is a small, short trial; semaglutide is not approved for alcohol use disorder.[4]

Heard vs evidence

"You cannot drink at all on it."
The labels do not prohibit alcohol. The reasons for care are nausea, low blood sugar with some diabetes medicines, and dehydration.[1][2][3]
"It cures drinking problems."
One small 9-week trial found less drinking per occasion, not fewer drinking days. Larger trials are underway.[4]

The short version

Short on the way. A 35-second captioned version of this page is in production for the Fewer Bites channel. It will be embedded here when it is live.

Questions to bring to your prescriber

Print these or screenshot them. They are conversation starters, not a checklist of things to do.

  • With my medicines and history, is there a level of drinking you would want me to stay under?
  • If I take insulin or a sulfonylurea, what should I know about alcohol and low blood sugar?
  • If I have noticed I drink less, or more, should we talk about it?

Education, not advice. This page explains what trials, labels and guidelines report. It does not tell anyone to start, change or stop a medicine. Your prescriber knows your history; this page does not.

Sources

Every number on this page traces to one of these. "Primary read" means the full paper or label was read; "abstract only" means only the abstract was available; "secondary" means the figure was taken from a named review.

  1. Novo Nordisk / FDA. Wegovy (semaglutide) injection and tablets, prescribing information, revised 06/2026. label
  2. Eli Lilly / FDA. Zepbound (tirzepatide) prescribing information, revised 08/2026. label
  3. NHS. Semaglutide: side effects and advice. guidance
  4. Hendershot CS et al. Once-weekly semaglutide in adults with alcohol use disorder: a randomized clinical trial. JAMA Psychiatry 2025. abstract only · RCT · small (n=48)

All 35 questions